• About Genmab
    • About Genmab
    • Board of Directors
    • Management Team
    • Partnerships
    • FAQ
  • Science & Research
    • Products In Development
    • Licensing Opportunities
    • Clinical Trials
    • Introduction to Antibodies
    • Antibody Technology
    • UniBody Technology
    • Scientific Articles
  • Investor Center
    • Stock Quotes
    • Stock Information
    • Analysts
    • Events
    • Investor Contact
    • Corporate Documents
    • Warrant Scheme
  • Press Center
    • Recent News Releases
    • Archived News Releases
    • Press Contact
  • Careers
    • Career Opportunities
    • Denmark
  • Contact Genmab
    • Contact Genmab
    • Subscribe to Genmab News

Hot News

Genmab to attend Kempen & Co Life Sciences ...»
Genmab Announces Results from Zalutumumab Phase III Study of Refractory Head and Neck Cancer Patients...»
Genmab Announces Year End 2009 Financial Results...»
Arzerra 2009 Net Sales Figures...»
More Genmab News Releases

Investor Center

  • Stock Quotes
  • Stock Information
  • Analysts
  • Events
  • Investor Contact
  • Corporate Documents
  • Warrant Scheme
  • Home
Print

Legal Notice
Use of this Site is subject to Important Legal Terms, which you are requested to read prior to proceeding.
© 2009 Genmab A/S
Investor Center » Events
2010»»   
2010  
Jan 7, 2010
SEB Enskilda Nordic Seminar, Copenhagen, Denmark
Mar 23, 2010
Kempen & Co. Life Sciences Conference, Brussels, Belgium